Paper41348428
The Therapeutic Potential of Dual NMR (NOP/MOP) Agonism in Pain Management.
Ciccocioppo R and 6 others. Pain Ther, 2026. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Therapeutic Potential of Dual NMR (NOP/MOP) Agonism in Pain Management. Papers, record 41348428. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41348428
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References158
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9,610,886 | Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. | Trends Neurosci | 1998 | https://conductscience.org/library/papers/9610886 | PubMed |
| 2 | 10,464,356 | Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. | J Comp Neurol | 1999 | https://conductscience.org/library/papers/10464356 | PubMed |
| 3 | 29,852,083 | Endogenous and Exogenous Opioids in Pain. | Annu Rev Neurosci | 2018 | https://conductscience.org/library/papers/29852083 | PubMed |
| 4 | 25,752,320 | Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates. | Br J Pharmacol | 2015 | https://conductscience.org/library/papers/25752320 | PubMed |
| 5 | 15,973,913 | Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. | Anaesth Intensive Care | 2005 | https://conductscience.org/library/papers/15973913 | PubMed |
| 6 | 28,112,482 | Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain. | Pain Pract | 2017 | https://conductscience.org/library/papers/28112482 | PubMed |
| 7 | 27,418,853 | A review of chronic pain impact on patients, their social environment and the health care system. | J Pain Res | 2016 | https://conductscience.org/library/papers/27418853 | PubMed |
| 8 | 9,987,804 | The induction of pain: an integrative review. | Prog Neurobiol | 1999 | https://conductscience.org/library/papers/9987804 | PubMed |
| 9 | 17,980,908 | Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation. | Neuropeptides | 2007 | https://conductscience.org/library/papers/17980908 | PubMed |
| 10 | 21,040,438 | Causes and consequences of inadequate management of acute pain. | Pain Med | 2010 | https://conductscience.org/library/papers/21040438 | PubMed |
| 11 | 9,527,501 | Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. | Eur J Pharmacol | 1997 | https://conductscience.org/library/papers/9527501 | PubMed |
| 12 | 38,364,970 | Pharmacological blockage of NOP receptors decreases ventral tegmental area dopamine neuronal activity through GABAB receptor-mediated mechanism. | Neuropharmacology | 2024 | https://conductscience.org/library/papers/38364970 | PubMed |
| 13 | 29,026,331 | Poorly controlled postoperative pain: prevalence, consequences, and prevention. | J Pain Res | 2017 | https://conductscience.org/library/papers/29026331 | PubMed |
| 14 | 32,525,759 | Cellular Circuits in the Brain and Their Modulation in Acute and Chronic Pain. | Physiol Rev | 2021 | https://conductscience.org/library/papers/32525759 | PubMed |
| 15 | 34,884,757 | Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884757 | PubMed |
| 16 | 35,947,066 | OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effects. | Behav Pharmacol | 2022 | https://conductscience.org/library/papers/35947066 | PubMed |
| 17 | 32,747,458 | Differential Modulation of Ventral Tegmental Area Circuits by the Nociceptin/Orphanin FQ System. | eNeuro | 2020 | https://conductscience.org/library/papers/32747458 | PubMed |
| 18 | 26,290,245 | Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization. | J Neurosci | 2015 | https://conductscience.org/library/papers/26290245 | PubMed |
| 19 | 8,982,509 | Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. | Br J Pharmacol | 1996 | https://conductscience.org/library/papers/8982509 | PubMed |
| 20 | 30,531,478 | Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study. | J Clin Psychopharmacol | 2019 | https://conductscience.org/library/papers/30531478 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,941,457 | Nociceptin/Orphanin FQ Peptide (NOP) Receptor Agonists as Novel Analgesics in Pain Medicine. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941457 | PubMed |
| 42,515,800 | Preclinical Evaluation of Dual NOP/Mu Partial Agonists for Methamphetamine Use Disorder. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515800 | PubMed |
| 42,420,592 | Structural basis for dual targeting of μ-opioid and nociceptin/orphanin FQ receptors by Cebranopadol. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42420592 | PubMed |
| 42,100,792 | Chronic Pain: Epidemiology, Pathophysiology, and Clinical Management. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42100792 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| OPRM1 | 4,988 | PubTator's text mining | https://conductscience.org/library/genes/4988 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41348428
GET https://conductscience.org/api/papers/v1/41348428/references?page=2